Fibrin Sealant Patch for the Management of Intractable Bleeding From an LVAD Apex Cannula
DOI:
https://doi.org/10.1532/hsf.4081Keywords:
Left Ventricular Assist Device, Fibrin Sealant Patch, Heart FailureAbstract
Background: Intractable bleeding from the apical cannulation site of a left ventricular assist device (LVAD) is a dreaded complication.
Case report: A 52-year-old male suffering from dilative cardiomyopathy (DCM) with fixed pulmonary hypertension underwent reoperative LVAD implantation after previous mitral valve surgery. The patient underwent three rethoracotomies for bleeding from the apex cannulation site without achieving hemostasis. Conventional techniques and application of fibrin sealants and polymeric sealing devices did not fix the problem. The bleeding stopped after application of the EVARREST® Fibrin Sealant Patch (FSP), and he needed no further transfusions.
Conclusion: This patch might become a useful tool for intractable bleeding problems in LVAD surgery.
References
Bruckner BA, DiBardino DJ, Ning Q, et al. 2009. High incidence of thromboembolic events in left ventricular assist device patients treated with recombinant activated factor VII. J Heart Lung Transplant. 28: 785-90.
Corral M, Ferko N, Hogan A, et al. 2016. A hospital cost analysis of a fibrin sealant patch in soft tissue and hepatic surgical bleeding. Clinicoecon Outcomes Res. 8: 507-519.
Ding H, Yuan JQ, Zhou JH, et al. 2013. Systematic review and meta-analysis of application of fibrin sealant after liver resection. Curr Med Res Opin. 29: 387-394.
Fischer CP, Bochicchio G, Shen J, et al. 2013. A prospective, randomized, controlled trial of the efficacy and safety of fibrin pad as an adjunct to control soft tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic surgery. J Am Coll Surg. 217:385–393.
Kasirajan V, McCarthy PM, Hoercher KJ, et al. 2000. Clinical experience with long-term use of implantable left ventricular assist devices: indications, implantation, and outcomes. Semin Thorac Cardiovasc Surg. 12:229-37.
Koea J, Baldwin P, Shen J, et al. 2015. Safety and hemostatic effectiveness of the fibrin pad for severe soft-tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic (non-cardiac) surgery: a randomized, controlled, superiority trial. World J Surg. 39: 2663–2669.
Slaughter MS, Rogers JG, Milano CA, et al. 2009. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 361:2241-51.
Stokes ME, Ye X, Shah M, et al. 2011. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res. 11:135.
